Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05370807
Title A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma (RegoMel)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universitair Ziekenhuis Brussel
Indications

melanoma

Therapies

Regorafenib

Age Groups: adult | senior
Covered Countries BEL


No variant requirements are available.